A new drug for early breast cancer… its first appearance in 20 years

A new drug for early breast cancer… its first appearance in 20 years
A new drug for early breast cancer… its first appearance in 20 years

GMT 15:13 20.10.2021Copy the link


Arabic – News, Opinions & Radio Sputnik





The US Food and Drug Administration (FDA) on Wednesday approved a new drug for one type of breast cancer, a development that one scientist says is the first real progress in 20 years.

“This is the first time in more than 20 years that we are seeing advances in treatment,” lead researcher Stephen Johnston, MD from the Royal Marsden Hospital NHS Foundation Trust, in London, said at a recent meeting of the European Society of Medical Oncology. Adjuvant for this type of breast cancer,” according to the medical website MedWeb.

The new drug “will change the course of treatment,” said Giuseppe Corigliano, head of early drug development at the European Institute of Oncology in Milan, Italy.

The drug called abemaciclib — the brand name Verzenio — is now approved for patients with early HR+, ER2 breast cancer, which makes up 70% of all breast cancers.

October every year is Breast Cancer Awareness Month in all countries of the world.

The month of October helps to increase interest in this disease and provide the necessary support to raise awareness of its seriousness and early detection and treatment, as well as providing patients with it with palliative care, according to the World Health Organization.

Sputnik / M.HASSAN

“The 12 best foods for women”… “Protects them from breast cancer and strengthens bones”


drug early breast cancer appearance years

For Latest Updates Follow us on Google News

NEXT Watch: 110: 112 Dramatic for Brooklyn over the Knicks